Theobromine for use in the treatment of increasing HDL-cholesterol and/or increasing the ratio HDL-cholesterol : LDL-cholesterol in humans and the use of theobromine for increasing HDL-cholesterol in humans and/or for increasing the ratio HDL-C / LDL-C and compositions comprising theobromine.

FIELD: medicine.SUBSTANCE: present invention refers to a prolonged release tablet containing theobromine and comprising a prolonged release layer and a fast release layer wherein the prolonged release layer consists of 40-60 wt % of theobromine as an active ingredient and 14-19 wt % of a prolonged release base consisting of polyethylene oxide and hydroxypropyl methylcellulose and the fast release layer consists of 10-30 wt % of theobromine as an active ingredient and 0.5-2 wt % of an aerating ag...

Compositions and methods for reducing oral sensitivity, increasing the systemic health of a mammal, occluding a dentinal tubule within a mammalian tooth, and/ or depositing a precipitate on the surface of a mammalian tooth are provided, said compositions comprising theobromine (3,7-dimethylxanthine, the principal alkaloid in Theobroma cacao).

Provided are a method for easily promoting the solidification of a lipid composition, preferably a lipid composition for food or cosmetics, said lipid composition comprising at least one member selected from among a fatty acid and a glycerin fatty acid ester, and a method for producing fractionated lipids whereby the aforesaid lipid composition is fractionated into a solid fraction and a liquid fraction. Monolayer particles or particles having a layered structure consisting of layers that are la...

Abstract 599949 The disclosure relates to an agent consisting of theobromine and another non-opiate antitussive, for use in therapy. Preferably, the therapy is of cough. The non-opiate antitussive (preferably a N-methyl-D-aspartate [NMDA] receptor antagonist) may be any of dextromethorphan, isoaminile, benzonate, zipeprol, morclofone, prenoxdiazine, dropropizine, piperidione, pentoxyverine, oxolamine, oxeladin, nepinalone, meprotixol, indantadol, dimemorfan, dibunate, cloperastine, clofedanol, b...

The object of the invention is to provide an agent which has good acceptability and stability and also gives rise to an antimicrobial effect. This object is achieved according to the invention in that the agent contains a purine or a purine alkaloid, the latter selected from the group consisting of xanthine, theobromine, paraxanthine, theophylline, 3-isobutyl-1-methylxanthine (IBMX) and 1-methylxanthine.

ABSTRACT - 600243 The disclosure relates to an agent consisting of theobromine and a decongestant as a combined preparation for use in a therapy of cough wherein the agent is manufactured for administration by an oral route wherein the decongestant is selected from ephedrine levmetamfetamine naphazoline oxymetazoline phenylephrine phenylpropanolamine propylhexedrine pseudoephedrine synephrine and tetrahydrozoline and wherein the decongestant preferably pseudoephedrine is to be administered in a ...